30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Embody Gains Additional Funding for ACL Repair -

Embody is receiving a $2.5 million Phase II research award through the Defense Advanced Research Projects Agency (DARPA), bringing its total DARPA funding to $14.35 million. The award will support development and clinical assessment of MICROBRACE™ ACL technology for anterior cruciate ligament repair. MICROBRACE for ACL is a stand-alone, off-the-shelf solution designed to immediately restore mechanical stability to the knee joint and gradually remodel over time. Embody is developing biomaterials with an initial focus on orthopedic applications such as Achilles, rotator cuff and knee ligament repair. Previously, the company has raised funding from cultivate(MD) and DARPA.